FRANKLIN LAKES, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Timothy C.
Wentworth, president and CEO of Accredo Health Group, Inc., the specialty
pharmacy subsidiary of Medco Health Solutions, Inc. (NYSE: MHS), is
scheduled to address the Raymond James 28th Annual Institutional Investors
Conference in Orlando, Fla. on Monday, March 5, 2007.
The Medco presentation, at the Hyatt Regency Grand Cypress, will begin
at 9:15 a.m. ET.
The presentation may be heard live via a simulcast link and the
accompanying slides will be available at http://www.medco.com/investor. Real
Player or Windows Media Player is required to listen to the webcast. Free
downloads of both players are available at the webcast site. The webcast
will be available for replay for one month following the presentation.
About Medco
Medco Health Solutions, Inc. (NYSE: MHS) is the nation's leading
pharmacy benefit manager based on its 2006 total net revenues of more than
$42 billion. Medco's prescription drug benefit programs are designed to
drive down the cost of pharmacy health care for private and public
employers, health plans, labor unions and government agencies of all sizes,
and for individuals served by the Medicare Part D Prescription Drug
Program. Medco's technologically advanced mail-order pharmacies and
award-winning Internet pharmacy have been recognized for setting new
industry benchmarks for pharmacy dispensing quality. Medco serves the needs
of patients with complex conditions requiring sophisticated treatment
through its specialty pharmacy operation, which became the nation's largest
with the 2005 acquisition of Accredo Health, Incorporated. Medco is the
highest-ranked pharmacy benefit manager on the 2006 Fortune 500 list. On
the Net: http://www.medco.com.
This press release contains "forward-looking statements" as that term
is defined in the Private Securities Litigation Reform Act of 1995. These
statements involve risks and uncertainties that may cause results to differ
materially from those set forth in the statements. No forward-looking
statement can be guaranteed, and actual results may differ materially from
those projected. We undertake no obligation to publicly update any forward-
looking statement, whether as a result of new information, future events,
or otherwise. Forward-looking statements in this press release should be
evaluated together with the risks and uncertainties that affect our
business, particularly those mentioned in the Risk Factors section of the
Company's Annual Report on Form 10-K filed with the Securities and Exchange
Commission.
SOURCE Medco Health Solutions, Inc.
 back to top
Related links:
http://www.medco.com
http://www.medco.com/investor
CONTACT:
Investors: Chela Bruno, +1-201-269-6430,
chela_bruno@medco.com, Media: Jennifer Luddy, +1-201-269-6402,
jennifer_luddy@medco.com, both of Medco Health Solutions, Inc.
|
